Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.23.5 (
cathepsin D
)
4,130
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A previous report has shown that progesterone up-regulates
cathepsin D
expression in human endometrial cell culture. In women using the levonorgestrel-releasing Implant
Norplant
, the plasma levonorgestrel and immunoreactive endometrial progesterone receptor concentrations are elevated. However, the functional status of these receptors is not known. This study used endometrial
cathepsin D
expression both as an indirect marker for the functional status of endometrial progesterone receptors, and to identify the cell types that express
cathepsin D
. The results show that
cathepsin D
is primarily found in glandular epithelia and luminal epithelia in control and
Norplant
endometria. There is no significant difference in
cathepsin D
expression between the control and
Norplant
endometria, between the various stages of the menstrual cycle, or between
Norplant
users with varying degrees of breakthrough bleeding. Cathepsin D is also detected in cells scattered in the stroma in both control and
Norplant
endometria. The majority of these cells are macrophages. These data indicate that there is no evidence for progesterone regulation of
cathepsin D
in the human endometrium. Cathepsin D thus cannot be used as a marker for the functional status of progesterone receptors found in the
Norplant
-exposed endometrium.
...
PMID:Immunohistochemical detection of cathepsin D in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle. 923 85